5 min read

EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Apr 14, 2026

10 signals (from 15 total). Healthcare leads (4). 5 with insider selling. 1 with congressional buying. 1 with congressional selling. price range $10-$444. RSI 36-67. sectors: Healthcare (4), Consumer Cyclical (3), Real Estate (2). 1 report earnings within 7 days. full analyst coverage

What This Signal Is (Quick)

This is an experimental strategy that combines two bullish signals occurring on the same day:

  1. Price crosses above EMA10 from below

    • Yesterday: price_prev <= ema10_prev
    • Today: price > ema10
    • Indicates price breaking above short-term trend
  2. MACD Line crosses above Signal Line from below

    • Yesterday: macd_line_prev <= macd_signal_prev
    • Today: macd_line > macd_signal
    • Confirms bullish momentum shift

Double Confirmation: Both crossovers must happen simultaneously on the signal date, providing higher-quality setups with stronger conviction.

Key Characteristics:

  • Buy signals only - This strategy generates only bullish signals (no sell signals)
  • Fewer but higher quality - Dual confirmation means 5-20 signals per day vs. 20-40 for single-indicator strategies
  • Fast response - EMA10 catches early momentum shifts
  • Momentum context - MACD adds underlying momentum confirmation
  • Swing trading focus - Ideal for 1-4 week holding periods

Key Criteria:

  • Buy: Price > EMA10 AND MACD line crosses above signal line

  • Sell: Price < EMA10 AND MACD line crosses below signal line

  • Minimum ADV: $40M (liquidity filter)

  • Earnings buffer: 7 days pre/post earnings

  • Fresh signal: All conditions met on today's close

Holding Period: 1-3 weeks
Risk Level: Medium-High


How We Ranked Today

Ranked by RSI (lower RSI = more oversold for buy signals)


📈 Buy-Side Signals (Top 10 of 15 total)

Ranked by RSI (lower RSI = more oversold for buy signals):

Rank Ticker Company Sector Last ($) RSI14 Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 COCO The Vita Coco Company,... Consumer Defensive 49.63 36.4 $-1.7M $2.53 2.8
2 SMR NuScale Power Corporation Industrials 10.25 40.5 $-162.9M $0.08 3.1
3 XPEV XPeng Inc. Consumer Cyclical 17.88 40.6 $3.02 17.0
4 TSLA Tesla, Inc. Consumer Cyclical 364.20 42.1 6 $11.38 1366.6
5 ARE Alexandria Real Estate... Real Estate 45.39 42.5 13 $-0.21 7.9
6 TENB Tenable Holdings, Inc. Technology 17.87 44.2 13 $2.42 2.1
7 DNLI Denali Therapeutics Inc. Healthcare 20.16 46.4 20 $1.40 3.2
8 DRI Darden Restaurants, Inc. Consumer Cyclical 197.98 47.0 $-641K $15.74 22.8
9 VRTX Vertex Pharmaceuticals... Healthcare 444.28 47.6 20 $33.48 112.9
10 SUZ Suzano S.A. Basic Materials 9.69 50.2 22 $11.96 12.0

📉 Sell-Side Signals (0 Total)

Ranked by RSI (lower RSI = more oversold for buy signals):

No signals found.

Field Notes

Sector concentration: Healthcare (4), Consumer Cyclical (3), Real Estate (2)

Insider selling: SMR (NuScale Power Corporation, $-162.9M), ERAS (Erasca, Inc., $-1.6M), LH (Labcorp Holdings Inc., $-3.1M)

Near-term earnings: TSLA (Tesla, Inc.) report within 7 days. Higher volatility risk.

Data coverage: 33.3% insider, 20.0% congressional (1 recent/90d, 2 older/1y), 66.7% earnings, 100.0% analyst, 13.3% news


Peer Analysis

Understanding how these stocks relate to their industry peers:

TSLA (Tesla, Inc.): Leads 7 peers: TM ($211.55, +0.2%), F ($12.70, +4.5%), NIO ($6.58, +1.5%), LI ($18.74, -0.2%), GM ($79.46, +3.4%) | Peer of: TM ($211.55, +0.2%)

VRTX (Vertex Pharmaceuticals Incorporated): Leads 10 peers: MCK ($862.79, -0.2%), HCA ($498.66, +0.2%), MDT ($88.12, +0.1%), SNY ($47.64, +1.4%), REGN ($755.51, +1.2%) | Peer of: BMY ($58.08, +0.0%), CVS ($77.62, -0.6%), GSK ($59.18, +0.4%) and 5 more

SUZ (Suzano S.A.): Leads 10 peers: ALB ($189.86, +2.4%), RGLD ($271.52, +2.7%), AA ($71.86, -2.0%), HMY ($17.08, +3.3%), JHX ($21.21, +0.3%) | Peer of: AA ($71.86, -2.0%), ALB ($189.86, +2.4%), CF ($118.96, -2.2%) and 5 more

COCO (The Vita Coco Company, Inc.): Leads 10 peers: SAM ($236.38, -2.8%), CCU ($12.27, -1.4%), CHA ($10.17, +1.4%), CHEF ($66.19, +2.4%), UNFI ($47.44, +0.9%) | Peer of: AKO-A ($22.90, +2.5%), CCU ($12.27, -1.4%), CHA ($10.17, +1.4%) and 8 more

SMR (NuScale Power Corporation): Leads 8 peers: BIP ($37.23, +1.4%), SBS ($33.80, +0.4%), LNT ($72.30, -0.3%), KEP ($15.33, +5.0%), EVRG ($81.92, -0.6%) | Peer of: BEP ($34.84, +1.4%), BIP ($37.23, +1.4%), TLN ($345.76, +6.0%)

XPEV (XPeng Inc.): Leads 9 peers: LI ($18.74, -0.2%), NIO ($6.58, +1.5%), PHM ($122.68, +0.8%), RIVN ($15.99, +0.6%), ULTA ($533.09, +1.2%) | Peer of: LI ($18.74, -0.2%), PHM ($122.68, +0.8%), STLA ($8.16, +2.3%) and 2 more

DNLI (Denali Therapeutics Inc.): Leads 9 peers: RCUS ($23.01, +2.8%), AGIO ($33.30, +0.5%), IBRX ($7.60, +4.1%), BEAM ($30.30, +0.4%), RXRX ($3.54, +3.5%) | Peer of: AGIO ($33.30, +0.5%), BEAM ($30.30, +0.4%), BKD ($13.92, +2.4%) and 7 more

ARE (Alexandria Real Estate Equities, Inc.): Leads 9 peers: BXP ($55.03, +2.7%), KRC ($29.19, +1.6%), SLG ($40.66, +4.1%), VNO ($27.97, +1.6%), HIW ($22.84, +1.5%) | Peer of: BXP ($55.03, +2.7%), EGP ($195.10, +1.1%), REXR ($35.29, +1.8%) and 1 more

TENB (Tenable Holdings, Inc.): Leads 10 peers: DOCN ($73.45, -8.0%), WRD ($7.90, +4.0%), RELY ($17.92, +3.5%), SPSC ($52.55, -0.9%), VRNS ($21.76, -1.0%) | Peer of: DOCN ($73.45, -8.0%), RELY ($17.92, +3.5%), WRD ($7.90, +4.0%)

DRI (Darden Restaurants, Inc.): Leads 10 peers: QSR ($78.57, +1.4%), LI ($18.74, -0.2%), YUMC ($49.47, +0.1%), NVR ($6837.13, +0.9%), DPZ ($369.17, +0.1%) | Peer of: EXPE ($248.57, +3.5%), IHG ($144.24, +1.8%), IP ($36.54, -0.2%) and 8 more


Congressional Activity

SHOP (Shopify Inc.) 🔴 Bearish (90d)

  • 1 sale by 1 member
  • Top seller: Hou. Jonathan Jackson (IL) - 1 transaction ($50,001 - $100,000)
  • Top buyer: Hou. Jonathan Jackson (IL) - 1 transaction ($50,001 - $100,000)

LH (Labcorp Holdings Inc.) 🟢 Bullish (1y)

  • 1 purchase by 1 member
  • Top buyer: Hou. April Delaney (MD) - 1 transaction ($1,001 - $15,000)

TSLA (Tesla, Inc.) ⚪ Neutral (1y)

  • 2 total transactions: 1 purchases, 1 sales
  • Top seller: Hou. Lisa McClain (MI) - 1 transaction ($15,001 - $50,000)
  • Top buyer: Hou. Marjorie Taylor Greene (GA) - 1 transaction ($1,001 - $15,000)

Recent Headlines

ARE (Alexandria Real Estate Equities, Inc.)

  • REIT Replay: U.S. REIT Indexes Continue To Climb During Week Ended April 10 (source)
  • When No One Shows Up, Opportunity Does: The Office REIT Reset (source)
  • Panic In REITs Is Creating Generational Opportunities (source)

Market Context

Broad market indices advanced today, with the Nasdaq leading gains at +1.94%, followed by the S&P 500 at +1.17% and the Dow at +0.66%. This upward momentum reflects a bullish trend and heightened risk appetite, creating a favorable environment for short-term momentum strategies like EMA10 price MACD. These signals, which rely on price crossovers and histogram momentum, thrive in trending markets, potentially generating more reliable buy entries amid sustained buying pressure across major benchmarks.

The VIX declined sharply by 3.97% to 18.36, signaling reduced volatility and calmer intraday swings. Lower volatility minimizes noise and false crossovers in EMA10 and MACD readings, enhancing signal accuracy for intraday or swing trades. However, traders should remain cautious of any VIX rebound, as even moderate levels like 18 could amplify whipsaws in less liquid sectors.

With 15 total signals concentrated in Healthcare as the top sector, this points to rotation toward resilient areas amid the risk-on backdrop. While Nasdaq's outperformance suggests growth sensitivity, Healthcare's signal dominance implies defensive positioning within the broader uptrend, bolstering the strategy's edge in sectors less prone to volatility spikes.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (4 signals) suggests sector-specific rotation. 5 signals showing insider selling warrant caution.


Sharing Call-to-Action

💪 If this gave you insight, a quick like, share, or subscribe supports the continued work behind EverHint.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/